Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Pourquier

Showing results (1-10 of 35) with videos related to

Pageof 4
Sort By:
Bulletin Du Cancer|February 5, 1999
[Topoisomerases I: new targets for the treatment of cancer and mechanisms of resistance]P Pourquier, Y Pommier
Advances in Cancer Research|October 18, 2000
Topoisomerase I-mediated DNA damageP Pourquier, Y Pommier
Cancer Research|July 4, 1998
Purification and characterization of a Mg2+-dependent endonuclease (AN34) from etoposide-treated human leukemia HL-60 cells undergoing apoptosisA Yoshida, P Pourquier, Y Pommier
Cancer Research|October 23, 1997
Aclacinomycin A stabilizes topoisomerase I covalent complexesJ L Nitiss, P Pourquier, Y Pommier
The Journal of Biological Chemistry|October 9, 1998
Induction of topoisomerase I cleavage complexes by the vinyl chloride adduct 1,N6-ethenoadenineP Pourquier, M A Bjornsti, Y Pommier
Anti-Cancer Drugs|June 13, 1998
Transcriptional down-regulation of c-myc expression in an erythroleukemic cell line, K562, and its doxorubicin-resistant variant by two topoisomerase II inhibitors, doxorubicin and amsacrineA Clary, A Larrue, P Pourquier, et al.
Biochimica Et Biophysica Acta|September 28, 1998
Mechanism of action of eukaryotic DNA topoisomerase I and drugs targeted to the enzymeY Pommier, P Pourquier, Y Fan, et al.
Methods in Molecular Medicine|March 5, 2011
Topoisomerase I and II Activity AssaysP Pourquier, G Kohlhagen, L M Ueng, et al.
European Journal of Biochemistry|January 15, 1993
Doxorubicin-induced lipid peroxidation and glutathione peroxidase activity in tumor cell lines selected for resistance to doxorubicinM N Benchekroun, P Pourquier, B Schott, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 23, 1999
Poisoning of human DNA topoisomerase I by ecteinascidin 743, an anticancer drug that selectively alkylates DNA in the minor grooveY Takebayashi, P Pourquier, A Yoshida, et al.
Pageof 4

Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
Bulletin Du Cancer|February 5, 1999
[Topoisomerases I: new targets for the treatment of cancer and mechanisms of resistance]P Pourquier, Y Pommier
Advances in Cancer Research|October 18, 2000
Topoisomerase I-mediated DNA damageP Pourquier, Y Pommier
Cancer Research|July 4, 1998
Purification and characterization of a Mg2+-dependent endonuclease (AN34) from etoposide-treated human leukemia HL-60 cells undergoing apoptosisA Yoshida, P Pourquier, Y Pommier
Cancer Research|October 23, 1997
Aclacinomycin A stabilizes topoisomerase I covalent complexesJ L Nitiss, P Pourquier, Y Pommier
The Journal of Biological Chemistry|October 9, 1998
Induction of topoisomerase I cleavage complexes by the vinyl chloride adduct 1,N6-ethenoadenineP Pourquier, M A Bjornsti, Y Pommier
Anti-Cancer Drugs|June 13, 1998
Transcriptional down-regulation of c-myc expression in an erythroleukemic cell line, K562, and its doxorubicin-resistant variant by two topoisomerase II inhibitors, doxorubicin and amsacrineA Clary, A Larrue, P Pourquier, et al.
Biochimica Et Biophysica Acta|September 28, 1998
Mechanism of action of eukaryotic DNA topoisomerase I and drugs targeted to the enzymeY Pommier, P Pourquier, Y Fan, et al.
Methods in Molecular Medicine|March 5, 2011
Topoisomerase I and II Activity AssaysP Pourquier, G Kohlhagen, L M Ueng, et al.
European Journal of Biochemistry|January 15, 1993
Doxorubicin-induced lipid peroxidation and glutathione peroxidase activity in tumor cell lines selected for resistance to doxorubicinM N Benchekroun, P Pourquier, B Schott, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 23, 1999
Poisoning of human DNA topoisomerase I by ecteinascidin 743, an anticancer drug that selectively alkylates DNA in the minor grooveY Takebayashi, P Pourquier, A Yoshida, et al.
Pageof 4